Search Results - "Yasri, Aziz"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Antioxidant Activity Improvement of Apples Juice Supplemented with Chitosan-Galactose Maillard Reaction Products by Hafsa, Jawhar, Smach, Mohamed Ali, Sobeh, Mansour, Majdoub, Hatem, Yasri, Aziz

    Published in Molecules (Basel, Switzerland) (12-12-2019)
    “…Chitosan-galactose Maillard reaction (CG) were prepared by heating at 100 °C for 3 hrs in a model system containing chitosan (CH) and 1%, 1.5% and 2% ( / ) of…”
    Get full text
    Journal Article
  2. 2

    Axl kinase as a key target for oncology: focus on small molecule inhibitors by Feneyrolles, Clémence, Spenlinhauer, Aurélia, Guiet, Léa, Fauvel, Bénédicte, Daydé-Cazals, Bénédicte, Warnault, Pierre, Chevé, Gwénaël, Yasri, Aziz

    Published in Molecular cancer therapeutics (01-09-2014)
    “…Receptor tyrosine kinases (RTK) are transmembrane receptors that regulate signal transduction in cells. As a member of the TAM (Tyro-3, Axl, Mer) RTK…”
    Get full text
    Journal Article
  3. 3

    HPLC-ESI- MS/MS analysis of beet (Beta vulgaris) leaves and its beneficial properties in type 1 diabetic rats by Abd El-Ghffar, Eman A., Hegazi, Nesrine M., Saad, Hamada H., Soliman, Mohamed M., El-Raey, Mohamed A., Shehata, Safia M., Barakat, Alaa, Yasri, Aziz, Sobeh, Mansour

    Published in Biomedicine & pharmacotherapy (01-12-2019)
    “…[Display omitted] The phenolic profile of the leaves of Beta vulgaris subspecies vulgaris variety rubra was investigated by high-performance liquid…”
    Get full text
    Journal Article
  4. 4

    Chrysophanol, Physcion, Hesperidin and Curcumin Modulate the Gene Expression of Pro-Inflammatory Mediators Induced by LPS in HepG2: In Silico and Molecular Studies by Selim, Nabil Mohamed, Elgazar, Abdullah Abdurrahman, Abdel-Hamid, Nabil Mohie, El-Magd, Mohammed Rizk Abu, Yasri, Aziz, Hefnawy, Hala Mohamed El, Sobeh, Mansour

    Published in Antioxidants (03-09-2019)
    “…Hepatitis is an inflammatory condition that can develop hepatocellular carcinoma. Traditional medicine has always been the pillar of medical practice. However,…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Structural elucidation of the DFG-Asp in and DFG-Asp out states of TAM kinases and insight into the selectivity of their inhibitors by Messoussi, Abdellah, Peyronnet, Lucile, Feneyrolles, Clémence, Chevé, Gwénaël, Bougrin, Khalid, Yasri, Aziz

    Published in Molecules (Basel, Switzerland) (10-10-2014)
    “…Structural elucidation of the active (DFG-Asp in) and inactive (DFG-Asp out) states of the TAM family of receptor tyrosine kinases is required for future…”
    Get full text
    Journal Article
  7. 7

    Salix tetrasperma Roxb. Extract Alleviates Neuropathic Pain in Rats via Modulation of the NF-κB/TNF-α/NOX/iNOS Pathway by Sobeh, Mansour, Mahmoud, Mona F., Rezq, Samar, Alsemeh, Amira E., Sabry, Omar M., Mostafa, Islam, Abdelfattah, Mohamed A. O., Ait El-Allem, Khadija, El-Shazly, Assem M., Yasri, Aziz, Wink, Michael

    Published in Antioxidants (12-10-2019)
    “…Patients with neuropathic pain experience chronic painful tingling, burning, and prickling sensations accompanied with hyperalgesia and/or allodynia. In this…”
    Get full text
    Journal Article
  8. 8
  9. 9

    REALISIS:  A Medicinal Chemistry-Oriented Reagent Selection, Library Design, and Profiling Platform by Yasri, Aziz, Berthelot, Didier, Gijsen, Harry, Thielemans, Theo, Marichal, Patrick, Engels, Michael, Hoflack, Jan

    “…REALISIS is a software system for reagent selection, library design, and profiling, developed to fit the workflow of bench chemists and medicinal chemists…”
    Get full text
    Journal Article
  10. 10

    Antibodies directed against receptor tyrosine kinases: Current and future strategies to fight cancer by FAUVEL, Bénédicte, Yasri, Aziz

    Published in mAbs (01-07-2014)
    “…Approximately 30 therapeutic monoclonal antibodies have already been approved for cancers and inflammatory diseases, and monoclonal antibodies continue to be…”
    Get full text
    Journal Article
  11. 11

    Recent Progress in the Design, Study, and Development of c-Jun N-Terminal Kinase Inhibitors as Anticancer Agents by Messoussi, Abdellah, Feneyrolles, Clémence, Bros, Aurélie, Deroide, Arthur, Daydé-Cazals, Bénédicte, Chevé, Gwénaël, Van Hijfte, Nathalie, Fauvel, Bénédicte, Bougrin, Khalid, Yasri, Aziz

    Published in Chemistry & biology (20-11-2014)
    “…The c-Jun N-terminal kinase (JNK) family, with its three members JNK1, JNK2, and JNK3, is a subfamily of mitogen-activated protein kinases. Involved in many…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Design, synthesis, and biological evaluation of bifunctional thyrointegrin inhibitors: new anti-angiogenesis analogs by Bridoux, Alexandre, Khan, Riaz A, Chen, Celei, Chevé, Gwenaël, Cui, Huadong, Dyskin, Evgeny, Yasri, Aziz, Mousa, Shaker A

    “…Inhibition of pathological angiogenesis. Obtaining new transactivator, bifunctional, thyroid antagonist, non-toxic anti-angiogenic compounds. In silico drug…”
    Get more information
    Journal Article